Loading clinical trials...
Loading clinical trials...
A Phase 1b Study of SAR650984 (Isatuximab) in Combination With Pomalidomide and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma
Conditions
Interventions
Isatuximab SAR650984
Pomalidomide
+1 more
Locations
13
United States
Investigational Site Number 840001
Scottsdale, Arizona, United States
Investigational Site Number 840006
Duarte, California, United States
Investigational Site Number 840018
New Haven, Connecticut, United States
Investigational Site Number 840011
Decatur, Illinois, United States
Investigational Site Number 840004
Boston, Massachusetts, United States
Investigational Site Number 840104
Boston, Massachusetts, United States
Start Date
May 15, 2015
Primary Completion Date
May 26, 2021
Completion Date
May 26, 2021
Last Updated
July 9, 2021
NCT06356571
NCT05334069
NCT05312255
NCT04508790
NCT04876248
NCT04640779
Lead Sponsor
Sanofi
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions